EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Predictors of Outcome in a Contemporary Cardiac Sarcoidosis Population: Role of Brain Natriuretic Peptide, Left Ventricular Function and Myocardial Inflammation

Vasileios Kouranos iD, Rajdeep S Khattar, Joseph Okafor, Raheel Ahmed, Alessia Azzu, John Arun Baksi, Kshama Wechalekar, Martin R Cowie, Athol Umfrey Wells, Thomas F Lüscher, Rakesh Sharma

European Journal of Heart Failure · 2023

DOI: 10.1002/ejhf.3057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, 2023. Verfasst von Vasileios Kouranos und 10 weiteren Autor:innen. Beteiligte Einrichtung: Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK. Hauptthemen laut MEDLINE: Cardiomyopathies, Heart Failure, Myocarditis, Sarcoidosis. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cardiac sarcoidosis (CS) is a potentially fatal condition that varies in its clinical presentation. Here, we describe baseline characteristics at presentation along with prognosis and predictors of outcome in a sizable and deeply phenotyped contemporary cohort of CS patients. Methods and results Consecutive CS patients seen at one institution were retrospectively enrolled after undergoing laboratory testing, electrocardiogram, echocardiography, cardiac magnetic resonance (CMR) imaging and 18F-flourodeoxyglucose positron emission tomography (FDG-PET) at baseline. The composite endpoint consisted of all-cause mortality, aborted sudden cardiac death, major ventricular arrhythmic events, heart failure hospitalization and heart transplantation. A total of 319 CS patients were studied (67% male, 55.4 ± 12 years). During a median follow-up of 2.2 years (range: 1 month–11 years), 8% of patients died, while 33% reached the composite endpoint. The annualized mortality rate was 2.7% and the 5- and 10-year mortality rates were 6.2% and 7.5%, respectively. Multivariate analysis showed serum brain natriuretic peptide (BNP) levels (hazard ratio [HR] 2.41, 95% confidence interval [CI] 1.34–4.31, p = 0.003), CMR left ventricular ejection fraction (LVEF) (HR 0.96, 95% CI 0.94–0.98, p < 0.0001) and maximum standardized uptake value of FDG-PET (HR 1.11, 95% CI 1.04–1.19, p = 0.001) to be independent predictors of outcome. These findings remained robust for different patient subgroups.

Conclusion

Cardiac sarcoidosis is associated with significant morbidity and mortality, particularly in those with cardiac involvement as the first manifestation. Higher BNP levels, lower LVEF and more active myocardial inflammation were independent predictors of outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesHeart FailureMyocarditisSarcoidosisFemaleHumansMaleFluorodeoxyglucose F18InflammationNatriuretic Peptide, BrainPrognosisRetrospective StudiesStroke VolumeVentricular Function, LeftAdultMiddle AgedAged

Stichwörter der Autor:innen

Brain natriuretic peptideInflammationLeft ventricular impairmentPrognosisSarcoidosis

Substanzen

Fluorodeoxyglucose F18Natriuretic Peptide, Brain

Autor:innen und Institutionen

  • Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.
  • National Heart & Lung Institute, Imperial College London, London, UK.
  • Department of Echocardiography, Royal Brompton Hospital, London, UK.
  • Department of Cardiology, Royal Brompton Hospital, London, UK.
  • Cardiac Magnetic Resonance Imaging Department, Royal Brompton Hospital, London, UK.
  • Nuclear Medicine Department, Royal Brompton Hospital, London, UK.

ORCID-Profile: Vasileios Kouranos

Zitieren

APA

Kouranos, V., Khattar, R. S., Okafor, J., Ahmed, R., Azzu, A., Baksi, J. A., Wechalekar, K., Cowie, M. R., Wells, A. U., Lüscher, T. F., & Sharma, R. (2023). Predictors of Outcome in a Contemporary Cardiac Sarcoidosis Population: Role of Brain Natriuretic Peptide, Left Ventricular Function and Myocardial Inflammation. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3057

Vancouver

Kouranos V, Khattar RS, Okafor J, Ahmed R, Azzu A, Baksi JA, et al. Predictors of Outcome in a Contemporary Cardiac Sarcoidosis Population: Role of Brain Natriuretic Peptide, Left Ventricular Function and Myocardial Inflammation. European Journal of Heart Failure. 2023. doi:10.1002/ejhf.3057

BibTeX
@article{Kouranos2023,
  author = {Kouranos, Vasileios and Khattar, Rajdeep S and Okafor, Joseph and Ahmed, Raheel and Azzu, Alessia and Baksi, John Arun and Wechalekar, Kshama and Cowie, Martin R and Wells, Athol Umfrey and Lüscher, Thomas F and Sharma, Rakesh},
  title = {Predictors of Outcome in a Contemporary Cardiac Sarcoidosis Population: Role of Brain Natriuretic Peptide, Left Ventricular Function and Myocardial Inflammation},
  journal = {European Journal of Heart Failure},
  year = {2023},
  doi = {10.1002/ejhf.3057}
}
Kostenlos starten →